Glycosylation protects proteins against free radicals generated from toxic xenobiotics

Toxicological Sciences

Volumn 117, Issue 2, 2010, Pages 359-374

  Martínek, Václav ^a   Sklenář, Jan ^b   Dračínský, Martin ^c   Šulc, Miroslav ^a,b   Hofbauerová, Kateřina ^b   Bezouška, Karel ^a,b   Frei, Eva ^d   Stiborová, Marie ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^c INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

(glyco)protein modification by free radicals; Ellipticine; Free radicals; Glycosylation; HRP; Sudan I (1 phenylazo 2 naphthol)

Indexed keywords

ASIALOFETUIN; BOVINE SERUM ALBUMIN; ELLIPTICINE; FETUIN; FREE RADICAL; GALACTOSE; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLYCOSYLATED PROTEIN; HUMAN SERUM ALBUMIN; MANNOSE; N ACETYLGLUCOSAMINE; OLIGOSACCHARIDE; OROSOMUCOID; OVALBUMIN; OVOMUCOID; POLYPEPTIDE; RIBONUCLEASE; RIBONUCLEASE A; SUDAN I; TAMM HORSFALL GLYCOPROTEIN; XENOBIOTIC AGENT;

ARTICLE; GLYCOSYLATION; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; OXIDATION; PROTEIN BINDING;

CARCINOGENS; ELLIPTICINES; FREE RADICALS; GLYCOSYLATION; HUMANS; NAPHTHOLS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOSACCHARIDES; OXIDATION-REDUCTION; RIBONUCLEASE, PANCREATIC; RIBONUCLEASES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; UNCOUPLING AGENTS;

EID: 77956940791     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq206     Document Type: Article

References (83)

1. Bařinka, C., Šácha, P., Sklenář, J., Man, P., Bezouška, K., Slusher, B. S., and Konvalinka, J. (2004). Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity. Protein Sci. 13, 1627-1635.
2. Bauman, J. N., Kelly, J. M., Tripathy, S., Zhao, S. X., Lam, W. W., Kalgutkar, A. S., and Obach, R. S. (2009). Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepato-toxic drugs? An analysis using human hepatocytes and liver S-9 fraction. Chem. Res. Toxicol. 22, 332-340.
3. Beaune, P., Pessayre, D., Dansette, P., Mansuy, D., and Manns, M. (1994). Autoantibodies against cytochromes P450: role in human diseases. Adv. Pharmacol. 30, 199-245.
4. Beeley, J. G. (1971). The isolation of ovomucoid variants differing in carbohydrate composition. Biochem. J. 123, 399-405.
5. Bezouška, K. (2002). Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers). J. Biotechnol. 90, 269-290.
6. Bezouška, K. (2004). Carbohydrate and non-carbohydrate ligands for the C-type lectin-like receptors of natural killer cells. Collect. Czech. Chem. Commun. 69, 535-563.
7. Bezouška, K., Sklenář, J., Novák, P., Halada, P., Havlíček, V., Kraus, M., Tichá, M., and Jonáková, V. (1999). Determination of the complete covalent structure of the major glycoform of DQH sperm surface protein, a novel trypsin-resistant boar seminal plasma O-glycoprotein related to pB1 protein. Protein Sci. 8, 1551-1556.
8. Bořek-Dohalská, L., Hodek, P., Šulc, M., and Stiborová, M. (2001). α-Naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A6. Chem. Biol. Interact. 138, 85-106.
9. Bredow, M. T., and Goldie, D. J. (1985). Rapid falls in maternal serum alpha-fetoprotein concentrations. J. Clin. Pathol. 38, 473-474.
10. Chavan, M., and Lennarz, W. J. (2006). The molecular basis of coupling of translocation and N-glycosylation. Trends Biochem. Sci. 31, 17-20.
11. Chen, Y. R., Chen, C. L., Liu, X., Li, H., Zweier, J. L., and Mason, R. P. (2004). Involvement of protein radical, protein aggregation, and effects on NO metabolism in the hypochlorite-mediated oxidation of mitochondrial cytochrome c. Free Radic. Biol. Med. 37, 1591-1603.
12. Cohen, J. I., Roychowdhury, S., Dibello, P. M., Jacobsen, D. W., and Nagy, L. E. (2009). Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver. Hepatology 49, 1709-1717.
13. Davies, M. J., and Dean, R. T. (1997). Radical-Mediated Protein Oxidation: From Chemistry to Medicine. Oxford University Press, Oxford.
14. Díaz-Gómez, M., Fanelli, S., Delgado de Layño, A., Bietto, F., Castro, J., and Castro, G. (2008). Deleterious effects induced by oxidative stress in liver nuclei from rats receiving an alcohol-containing liquid diet. Toxicol. Ind. Health. 24, 625-634.
15. Dračínský, M., Cvačka, J., Semanská, M., Martínek, V., Frei, E., and Stiborová, M. (2009). The mechanism of formation of (deoxy)guanosine adducts derived from peroxidase-catalyzed oxidation of the carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxynaphthalene (Sudan I). Chem. Res. Toxicol. 29, 1765-1773.
16. Edge, A. S., and Spiro, R. G. (1987). Presence of an O-glycosidically linked hexasaccharide in fetuin. J. Biol. Chem. 262, 16135-16141.
17. Fletcher, A. P., Neuberger, A., and Ratcliffe, W. A. (1970). Tamm-Horsfall urinary glycoprotein. The chemical composition. Biochem. J. 120, 417-424.
18. Frei, E., Bieler, C. A., Arlt, V., Wiessler, M., and Stiborová, M. (2002). Covalent binding of the anticancer drug ellipticine to DNA in V79 cells transfected with human cytochrome P450 enzymes. Biochem. Pharmacol. 64, 289-295.
19. Giraud, A., Franc, J. L., Long, Y., and Ruf, J. (1992). Effects of deglycosylation of human thyroperoxidase on its enzymatic activity and immunoreactivity. J. Endocrinol. 132, 317-323.
20. Gray, J. S., Yang, B. Y., and Montgomery, R. (1998). Heterogeneity of glycans at each N-glycosylation site of horseradish peroxidase. Carbohydr. Res. 311, 61-69.
21. Green, E. D., Adelt, G., Baenziger, J. U., Wilson, S., and Van Halbeek, H. (1988). The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of N-glycanase-released oligosaccharides by 500-megahertz 1H NMR spectroscopy. J. Biol. Chem. 263, 18253-18268.
22. Hecht, S. S. (2008). Progress and challenges in selected areas of tobacco carcinogenesis. Chem. Res. Toxicol. 21, 160-171.
23. Imaoka, S., Osada, M., Minamiyama, Y., Yukimura, T., Toyokuni, S., Takemura, S., Hiroi, T., and Funae, Y. (2004). Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett. 203, 117-125.
24. Jacobs, P. P., and Callewaert, N. (2009). N-glycosylation engineering of biopharmaceutical expression systems. Curr. Mol. Med. 9, 774-800.
25. Joao, H. C., and Dwek, R. A. (1993). Effects of glycosylation on protein structure and dynamics in ribonuclease B and some of its individual glycoforms. Eur. J. Biochem. 218, 239-244.
26. Johansson, S., Giménez-Arnau, E., Grøtli, M., Karlberg, A. T., and Börje, A. (2008). Carbon- and oxygen-centered radicals are equally important haptens of allylic hydroperoxides in allergic contact dermatitis. Chem. Res. Toxicol. 21, 1536-1547.
27. Kakehi, K., Kinoshita, M., Kawakami, D., Tanaka, J., Sei, K., Endo, K., Oda, Y., Iwaki, M., and Masuko, T. (2001). Capillary electrophoresis of sialic acid-containing glycoprotein. Effect of the heterogeneity of carbohydrate chains on glycoform separation using an alpha1-acid glycoprotein as a model. Anal. Chem. 73, 2640-3647.
28. Kaplowitz, N., Aw, T. Y., Simon, F. R., and Stolz, A. (1986). Drug-induced hepatotoxicity. Ann. Intern. Med 104, 826-839.
29. Krieger, E., Darden, T., Nabuurs, S. B., Finkelstein, A., and Vriend, G. (2004). Making optimal use of empirical energy functions: force-field parameterization in crystal space. Proteins 57, 678-683.
30. Kurup, R. K., and Kurup, P. A. (2003). Hypothalamic digoxin, hemispheric chemical dominance, and mesenteric artery occlusion. Int. J. Neurosci. 113, 1141-1160.
31. Leone, A. M., Kao, L. M., McMillian, M. K., Nie, A. Y., Parker, J. B., Kelley, M. F., Usáli, E., Parkinson, A., Lord, P. G., and Johnson, M. D. (2007). Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression. Chem. Res. Toxicol. 20, 600-608.
32. Lesser, M. P. (2006). Oxidative stress in marine environments: biochemistry and physiological ecology. Annu. Rev. Physiol. 68, 253-278.
33. Liebler, D. C. (2008). Protein damage by reactive electrophiles: targets and consequences. Chem. Res. Toxicol. 21, 117-128.
34. Lis, H., and Sharon, N. (1993). Protein glycosylatiom. Structural and function aspects. Eur. J. Biochem. 218, 1-27.
35. Lytton, S. D., Helander, A., Zhang-Gouillon, Z. Q., Stokkeland, K., Bordone, R., Aricò, S., Albano, E., French, S. W., and Ingelman-Sundberg, M. (1999). Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics. Mol. Pharmacol. 55, 223-233.
36. Maleknia, S. D., and Downard, K. (2001). Radical approaches to probe protein structure, folding, and interactions by mass spectrometry. Mass Spectrom. Rev. 20, 388-401.
37. Mao, W., Iwai, C., Qin, F., and Liang, C. (2005). Norepinephrine induces endoplasmic reticulum stress and downregulation of norepinephrine transporter density in PC12 cells via oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 288, H2381-H2389.
38. Mareeva, E. A., Orlova, M. A., Doseeva, V. V., Loginov, D. B., Galkin, A. G., Gazarian, I. G., and Tishkov, V. I. (1996). Wild-type and mutant forms of recombinant horseradish peroxidase C expressed in Escherichia coli. Substrate specificity and stability under irradiation. Appl. Biochem. Biotechnol. 61, 13-23.
39. Margen, S., and Tarver, H. (1956). Comparative studies on the turnover of serum albumin in normal human subjects. J. Clin. Invest. 35, 1161-1172.
40. Maynes, J. T., Cherney, M. M., Quasi, H. A., Laskowski, M., Jr., and James, M. N. (2005). Structure of the subtilisin Carlsberg-OMTKY3 complex reveals two different ovomucoid conformations. Acta Crystallogr. D Biol. Crystallogr. 61, 580-585.
41. Nakamura, K., and Stadtman, E. R. (1984). Oxidative inactivation of glutamine synthetase subunits. Proc. Natl. Acad. Sci. U.S.A. 81, 2011-2015.
42. Naruszewicz, M., Zapolska-Downar, D., Kosmider, A., Nowicka, G., Kozlowska-Wojcie-chowska, M., Vikström, A. S., and Törnqvist, M. (2009). Chronic intake of potato chips in humans increases the production of reactive oxygen radicals by leukocytes and increases plasma C-reactive protein: a pilot study. Am. J. Clin. Nutr. 89, 773-779.
43. Nelson, S. D. (1995). Mechanisms of the formation and disposition of reactive metabolites that can cause acute liver injury. Drug Metab. Rev. 27, 147-177.
44. Niemelä, O. (2001). Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic. Biol. Med. 31, 1533-1538.
45. Obach, R. S., Kalgutkar, A. S., Soglia, J. R., and Zhao, S. X. (2008). Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose. Chem. Res. Toxicol. 21, 1814-1822.
46. Perera, F. P. (1995). Molecular epidemiology and prevention of cancer. Environ. Health Perspect. 103(Suppl. 8), 233-236.
47. Phillips, D. H. (2002). Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23, 1979-2004.
48. Rao, V., Guan, C., and Van Roey, P. (1995). Crystal structure of endo-β-N-acetylglucosaminidase H at 1.9 A resolution: active-site geometry and substrate recognition. Structure 3, 449-457.
49. Rauniyar, N., Stevens, S. M., Prokai-Tatrai, K., and Prokai, L. (2009). Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes. Anal. Chem. 81, 782-789.
50. Richard, E., Vega, A. I., Pérez, B., Roche, C., Velázquez, R., Ugarte, M., and Pérez-Cerdá, C. (2009). Congenital disorder of glycosylation Ia: new differentially expressed proteins identified by 2-DE. Biochem. Biophys. Res. Commun. 379, 267-271.
51. Rudd, P. M., Joao, M. C., Coghill, E., Fiten, P., Saunders, M. R., Opdenakker, G., and Dwek, R. A. (1994). Glycoforms modify the dynamic stability and functional activity of an enzyme. Biochemistry 23, 17-22.
52. Salomon, R. G., Kaur, K., and Batyreva, E. (2000). Isolevuglandin-protein adducts in oxidized low density lipoprotein and human plasma: a strong connection with cardiovascular disease. Trends Cardiovasc. Med. 10, 53-59.
53. Sei, K., Nakano, M., Kinoshita, M., Masuko, T., and Kakehi, K. (2002). Collection of alpha1-acid glycoprotein molecular species by capillary electrophoresis and the analysis of their molecular masses and carbohydrate chains. Basic studies on the analysis of glycoprotein glycoforms. J. Chromatogr. A 958, 273-281.
54. Serafini-Cessi, F., Dall'Olio, F., and Malagolini, M. (1984). High-mannose oligosaccharides from human Tamm-Horsfall glycoprotein. Biosci. Rep. 4, 269-274.
55. Shannon, L. M., Kay, E., and Lew, J. Y. (1966). Peroxidase isozymes from horseradish roots. I. Isolation and physical properties. J. Biol. Chem. 241, 2166-2172.
56. Silva, E., Edwards, A. M., and Faljoni-Alario, A. (1990). Enzymatic generation of triplet acetone by deglycosylated horseradish peroxidase. Arch. Biochem. Biophys. 276, 527-530.
57. 8glycoform of ribonuclease B with conglutinin. Glycobiology 11, 31-36.
58. Stadler, K., Bonini, M. G., Dallas, S., Jiang, J., Radi, R., Mason, R. P., and Kadiiska, M. B. (2008). Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetes. Free Radic. Biol. Med. 45, 866-874.
59. Stiborová, M., Asfaw, B., Frei, E., and Schmeiser, H. H. (1996). Oxidation of azo dyes by peroxidase: additional evidence of a one-electron mechanism of oxidation of dimethylaminoazobenzene and Sudan I (solvent yellow 14). Collect. Czech. Chem. Commun. 61, 962-972.
60. Stiborová, M., Bieler, C. A., Wiessler, M., and Frei, E. (2001a). The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts. Biochem. Pharmacol. 62, 675-684.
61. 32P-postlabeling. Int. J. Cancer. 107, 885-890.
62. 32P-postlabeling analysis of DNA adduct formation. Mutat. Res. 493, 149-160.
63. Stiborová, M., Frei, E., Schmeiser, H. H., Wiessler, M., and Anzenbacher, P. (1992). Peroxidase oxidizes N-nitrosomethylaniline to ultimate carcinogen(s) binding to DNA and transfer RNA in vitro. Cancer Lett. 63, 53-59.
64. 32P-postlabelling of DNA adducts derived from peroxidative activation of carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxynaphthalene (Sudan I). Carcinogenesis 11, 1843-1848.
65. Stiborová, M., Martínek, V., Rýdlová, H., Hodek, P., and Frei, E. (2002a). Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes. Cancer Res. 62, 5678-5684.
66. 5. Neuro Endocrinol. Lett. 27(Suppl. 2), 35-39.
67. Stiborová, M., Mikšanová, M., Havlíček, V., Schmeiser, H. H., and Frei, E. (2002b). Mechanism of peroxidase-mediated oxidation of carcinogenic o-anisidine and its binding to DNA. Mutat. Res. 500, 49-66.
68. Stiborová, M., Poljaková, J., Ryšlavá, H., Dračínský, M., Eckschlager, T., and Frei, E. (2007). Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydrox-yellipticine. Int. J. Cancer 120, 243-251.
69. Stiborová, M., Schmeiser, H. H., and Frei, E. (1999). Prostaglandin H synthase mediated oxidation and binding to DNA of a detoxication metabolite of carcinogenic Sudan I 1-(phenylazo)-2,6-dihydroxynaphthalene. Cancer Lett. 142, 53-60.
70. 2-oxide. Cancer Res. 64, 8374-8380.
71. Tarelli, E., Byers, H. L., Wilson, M., Roberts, G., Homer, K. A., and Beighton, D. (2000). Detecting mannosidase activities using ribonuclease B and matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Anal. Biochem. 282, 165-172.
72. Turesky, R. J. (2002). Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis. Drug Metab. Rev. 34, 625-650.
73. Uetrecht, J. P. (1997). Current trends in drug-induced autoimmunity. Toxicology 119, 37-43.
74. Van Lenten, L., and Ashwell, G. (1971). Studies on the chemical and enzymatic modification of glycoproteins. A general method for the tritiation of sialic acid-containing glycoproteins. J. Biol. Chem. 246, 1889-1894.
75. van Rooijen, J. J., Voskamp, A. F., Kamerling, J. P., and Vliegenthart, J. F. (1999). Glycosylation sites and site-specific glycosylation in human Tamm-Horsfall glycoprotein. Glycobiology 9, 21-30.
76. Varki, A. (1993). Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97-130.
77. Varki, A. (2008). Sialic acids in human health and disease. Trends Mol. Med. 14, 351-360.
78. Wang, J., Xu, G., Gonzales, V., Coonfield, M., Fromholt, D., Copeland, N. G., Jenkins, N. A., and Borchelt, D. R. (2002). Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol. Dis. 10, 128-138.
79. Welinder, K. G. (1979). Amino acid sequence studies of horseradish peroxidase. Amino and carboxyl termini, cyanogen bromide and tryptic fragments, the complete sequence, and some structural characteristics of horseradish peroxidase C. Eur. J. Biochem. 96, 483-502.
80. Williams, J. A., and Phillips, D. H. (2000). Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. Cancer Res. 60, 4667-4677.
81. Yan, Q., and Lennarz, W. J. (1999). Oligosaccharyltransferase: a complex multisubunit enzyme of the endoplasmic reticulum. Biochem. Biophys. Res. Commun. 266, 684-689.
82. Yasuno, S., Kokubo, K., and Kamei, M. (1999). New method for determining the sugar composition of glycoproteins, glycolipids, and oligosaccharides by high-performance liquid chromatography. Biosci. Biotechnol. Biochem. 63, 1353-1359.
83. Zenser, T. V., Lakshmi, V. M., Hsu, F. F., and Davis, B. B. (2002). Metabolism of N-acetylbenzidine and initiation of bladder cancer. Mutat. Res. 506-507, 29-40.